US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

VanEck Pharmaceutical ETF

87.36

-0.4401-0.50%

Volume:459.84K

Turnover:40.23M

Market Cap:553.70M

PE:70.79

High:88.03

Open:87.96

Low:87.07

Close:87.80

Loading ...

Overview Company News Filings

French Drugmaker Sanofi Clocks 20% Q1 Profit Growth, Forecasts Strong Rebound In Annual Profit

INmune Bio Receives Favorable Patentability Opinion for CORDStrom™ Platform Technology

PPHE Hotel (PPH) Gets a Buy from Kepler Capital

3 More Cyclical Stocks to Buy for 2025

PPHE Hotel Says Eli Papouchado To Step Down As Non-Executive Chairman

Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)?

Press Release: VanEck Announces Year-End Distributions for VanEck Equity ETFs

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/PPH/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PPH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PPH\",,,,,undefined,":{"symbol":"PPH","market":"US","secType":"STK","nameCN":"VanEck Pharmaceutical ETF","latestPrice":87.3599,"timestamp":1750439524842,"preClose":87.8,"halted":0,"volume":459838,"delay":0,"floatShares":6338138,"shares":6338138,"eps":1.234146,"marketStatus":"Trading","change":-0.4401,"latestTime":"06-20 13:12:12 EDT","open":87.96,"high":88.03,"low":87.065,"amount":40229424.05504,"amplitude":0.010991,"askPrice":87.35,"askSize":2160,"bidPrice":87.33,"bidSize":5,"shortable":3,"etf":1,"ttmEps":1.234146,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1750449600000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":87.8,"sharesOutstanding":6338138,"nav":87.81586,"aum":556589066.03,"dividendRate":0.01946,"bidAskSpread":0.000252,"postHourTrading":{"tag":"盘后","latestPrice":87.8,"preClose":87.8,"latestTime":"17:51 EDT","volume":12,"amount":1054.2,"timestamp":1750283491007},"volumeRatio":1.383554,"impliedVol":0.2088,"impliedVolPercentile":0.868},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PPH\",,,,,undefined,":{"symbol":"PPH","floatShares":6338138,"roa":"--","roe":"--","lyrEps":0.776475,"volumeRatio":1.383554,"shares":6338138,"dividePrice":1.7,"high":88.03,"amplitude":0.010991,"preClose":87.8,"low":87.065,"week52Low":77.67,"pbRate":"--","week52High":99.51,"institutionHeld":0,"latestPrice":87.3599,"committee":-0.995381,"eps":1.234146,"divideRate":0.01946,"volume":459838,"delay":0,"ttmEps":1.234146,"open":87.96,"prevYearClose":86.28,"prevWeekClose":90.78,"prevMonthClose":87.99,"prevQuarterClose":91.13,"fiveDayClose":91.78,"twentyDayClose":86.21,"sixtyDayClose":90.98},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PPH\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2529793925","title":"French Drugmaker Sanofi Clocks 20% Q1 Profit Growth, Forecasts Strong Rebound In Annual Profit","url":"https://stock-news.laohu8.com/highlight/detail?id=2529793925","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529793925?lang=en_us&edition=fundamental","pubTime":"2025-04-24 22:03","pubTimestamp":1745503410,"startTime":"0","endTime":"0","summary":"Sanofi Q1 2025 revenue rose 10.8% to $10.42 billion, driven by Dupixent and new launches, as earnings climbed 20.1% and 2025 guidance was reaffirmed.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/general/biotech/25/04/44981281/french-drugmaker-sanofi-clocks-20-q1-profit-growth-forecasts-strong-rebound-in-annual-profit","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","IPHA","IE00BFXG1179.USD","BK4007","SNYNF","BK4585","BK4139","PPH","SNY"],"gpt_icon":0},{"id":"2527221206","title":"INmune Bio Receives Favorable Patentability Opinion for CORDStrom™ Platform Technology","url":"https://stock-news.laohu8.com/highlight/detail?id=2527221206","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527221206?lang=en_us&edition=fundamental","pubTime":"2025-04-16 19:00","pubTimestamp":1744801200,"startTime":"0","endTime":"0","summary":"Boca Raton, Florida, US, April 16, 2025  --  INmune Bio Inc. , a clinical-stage biotechnology company targeting inflammation and immunology through the innate immune system, today announced a major intellectual property milestone with respect to its next-generation mesenchymal stromal cell  product, CORDStrom.The United States Patent and Trademark Office , acting as the International Search Authority, has issued a favorable written opinion on all claims in INmune Bio’s international patent application PCT/US25/17028, titled “THERAPEUTIC COMPOSITIONS COMPRISING POOLED, CULTURE-EXPANDED HUMAN UMBILICAL CORD DERIVED MESENCHYMAL STROMAL CELLS.” The written opinion, received April 8, 2025, confirms that all claims possess novelty, inventive step, and industrial applicability – key requirements for patentability under international standards.About CORDStromCORDStrom is a patent-pending cell medicine comprising aseptic, allogeneic, pooled human umbilical cord-derived mesenchymal stromal cells","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/inmune-bio-receives-favorable-patentability-110000576.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["MSC","INMB","BK4150","BK4575","BK4139","PPH"],"gpt_icon":0},{"id":"2526203086","title":"PPHE Hotel (PPH) Gets a Buy from Kepler Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2526203086","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526203086?lang=en_us&edition=fundamental","pubTime":"2025-04-12 09:45","pubTimestamp":1744422343,"startTime":"0","endTime":"0","summary":"In a report released on April 10, Julien Richer from Kepler Capital maintained a Buy rating on PPHE Hotel (PPH – Research Report), with a price tar...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/pphe-hotel-pph-gets-a-buy-from-kepler-capital-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/pphe-hotel-pph-gets-a-buy-from-kepler-capital-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PPH"],"gpt_icon":0},{"id":"2506369693","title":"3 More Cyclical Stocks to Buy for 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2506369693","media":"InvestorPlace","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506369693?lang=en_us&edition=fundamental","pubTime":"2025-01-27 01:00","pubTimestamp":1737910800,"startTime":"0","endTime":"0","summary":"Last week, I introduced two trading exchanges and three power-producing firms to buy. These cyclical firms are also quasi-monopolies. Even if there’s a down-cycle, they’re almost certain to weather the storm. This week, I’m pleased to add three more cyclical companies to that list.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://investorplace.com/2025/01/3-more-cyclical-stocks-to-buy-for-2025/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"investorplace_stock_picks","symbols":["ES","SG9999015986.USD","BK4559","FCX","LU1267930573.SGD","03160","PPH","LU1585245621.USD","LU2237443978.SGD","LU0070302665.USD","LU0980610538.SGD","LU2237443382.USD","BK4526","LU0170899867.USD","LU1880398471.USD","LU0795875086.SGD","SFTBY","LU2360106780.USD","ORCL","LU1983299246.USD","LU1035773651.USD","IE00B19Z3B42.SGD","SG9999003800.SGD","VIPS","LU1023059063.AUD","IE00BMPRXN33.USD","LU0788109121.HKD","LU1803068623.USD","KMB","LU1718418525.SGD","LU1244550577.SGD","BK4538","LU0211328371.USD","IE00BLSP4239.USD","LU0965509101.SGD","LU1642822529.SGD","LU2133065610.SGD","LU0861579265.USD","BK4220","LU0157215616.USD","LU0256863902.USD","LU0345781412.USD","FDN","BK4534","LU0823417737.USD","CME","LU0323591593.USD","BK4504","ABBV","IE0009355771.USD"],"gpt_icon":1},{"id":"2502014991","title":"PPHE Hotel Says Eli Papouchado To Step Down As Non-Executive Chairman","url":"https://stock-news.laohu8.com/highlight/detail?id=2502014991","media":"T-Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502014991?lang=en_us&edition=fundamental","pubTime":"2025-01-09 21:14","pubTimestamp":1736428492,"startTime":"0","endTime":"0","summary":"PPHE Hotel Group Ltd :Pphe Hotel: Eli Papouchado Has Decided To Step Aside From His Role As Non-Executive Chairman.Pphe Hotel:  Ken Bradley Appointed As Successor To Eli Papouchado.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.trkd.thomsonreuters.com","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PPH"],"gpt_icon":0},{"id":"2493713752","title":"Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)?","url":"https://stock-news.laohu8.com/highlight/detail?id=2493713752","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493713752?lang=en_us&edition=fundamental","pubTime":"2024-12-23 19:20","pubTimestamp":1734952806,"startTime":"0","endTime":"0","summary":"Looking for broad exposure to the Healthcare - Pharma segment of the equity market?You should consider the iShares U.S. Pharmaceuticals ETF , a passively managed exchange traded fund launched on 05/01/2006.Passively managed ETFs are becoming increasingly popular with institutional as well as retail investors due to their low cost, transparency, flexibility and tax efficiency. They are excellent vehicles for long term investors.Additionally, sector ETFs offer convenient ways to gain low risk and diversified exposure to a broad group of companies in particular sectors. Healthcare - Pharma is one of the 16 broad Zacks sectors within the Zacks Industry classification. It is currently ranked 3, placing it in top 19%.IShares U.S. Pharmaceuticals ETF holds a Zacks ETF Rank of 2 , which is based on expected asset class return, expense ratio, and momentum, among other factors. Because of this, IHE is a great option for investors seeking exposure to the Health Care ETFs segment of","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/xopQugjeNyS1VO21qlHkcQ--~B/aD02NzU7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/3cb5117fc22f5e37890d1860dcd61f9f","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/xopQugjeNyS1VO21qlHkcQ--~B/aD02NzU7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/3cb5117fc22f5e37890d1860dcd61f9f"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/invest-ishares-u-pharmaceuticals-etf-112006476.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0417517546.SGD","LU1732799900.SGD","IE00B2B36J28.USD","LU0098860793.USD","LU1989771016.USD","LU1804176565.USD","BK4588","LU0882574139.USD","SGXZ99366536.SGD","LU1221951129.SGD","LU2237438978.USD","LU0985481810.HKD","LU2237443895.HKD","LU1551013342.USD","LU1066051811.HKD","LU1430594728.SGD","LU1061106388.HKD","LU1291159041.SGD","LU1551013425.SGD","FDN","LU2491050071.SGD","BMY","IE00BK4W5M84.HKD","LU0320765059.SGD","JNJ","LU1032466523.USD","LU1064131342.USD","LU1894683348.USD","LU0256863902.USD","LU1674673691.USD","LU2063271972.USD","LU2023250504.SGD","BK4007","SG9999015978.USD","LU0689472784.USD","LU0640476718.USD","LLY","LU1267930813.SGD","PJP","PPH","SG9999015952.SGD","LU0109391861.USD","LU0238689110.USD","IHE","LU0320765646.SGD","LU0708995401.HKD","LU1066051225.USD","SGXZ81514606.USD","IE00BGHQF631.EUR","LU0306807586.USD"],"gpt_icon":1},{"id":"2493590402","title":"Press Release: VanEck Announces Year-End Distributions for VanEck Equity ETFs","url":"https://stock-news.laohu8.com/highlight/detail?id=2493590402","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493590402?lang=en_us&edition=fundamental","pubTime":"2024-12-21 09:56","pubTimestamp":1734746160,"startTime":"0","endTime":"0","summary":"VanEck announced today the following 2024 annual distributions per share for its VanEck equity exchange-traded funds.Distributions Per Share for the VanEck ETFs Listed Below. Ex-Date: December 23, 2024 | Record Date: December 23, 2024 | Payable Date: December 24, 2024. Fund             Ticker    Income    from PFICs        Gain       Capital Gain. Small-Cap ETF     BRF    $ 0.4483       1%            None          None. Sentiment ETF     BUZZ    $ 0.1246       <1%           None          None. Strategy ETF      CMCI    $ 0.9600      None           None          None. Refiners ETF      CRAK    $ 1.5394      None           None          None. eSports ETF      ESPO    $ 0.3650       42%           None          None. Services ETF       EVX    $ 0.7955      None           None          None. Miners ETF        GDX    $ 0.4025       5%            None          None","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ESPO","FDN","BK4535","BK4022","RTH","PPH","BK4550","DAPP","IBOT","BK4588","BK4232","BBH","SMHX","BK4585","BJK","EQR","RNEW","R","BK4215","SMH"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":7,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PPH\",params:#limit:5,,,undefined,":[{"date":"2025-04-01","symbol":"PPH","amount":0.5245,"announcedDate":"2025-03-31","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-04-01","defaultRemindTime":1743514200000,"name":"VanEck Pharmaceutical ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-04","payableDate":"2025-04-01","currency":"USD","dateTimestamp":1743480000000,"payDate":"2025-04-04"},{"date":"2024-12-27","symbol":"PPH","amount":0.411,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-27","defaultRemindTime":1735309800000,"name":"VanEck Pharmaceutical ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-30","payableDate":"2024-12-27","currency":"USD","dateTimestamp":1735275600000,"payDate":"2024-12-30"},{"date":"2024-10-01","symbol":"PPH","amount":0.409,"announcedDate":"2024-09-30","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-10-01","defaultRemindTime":1727789400000,"name":"VanEck Pharmaceutical ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-10-04","payableDate":"2024-10-01","currency":"USD","dateTimestamp":1727755200000,"payDate":"2024-10-04"},{"date":"2024-07-01","symbol":"PPH","amount":0.3558,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-07-01","name":"VanEck Pharmaceutical ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-05","payableDate":"2024-07-01","currency":"USD","dateTimestamp":1719806400000,"payDate":"2024-07-05"},{"date":"2024-04-01","symbol":"PPH","amount":0.5328,"announcedDate":"2024-03-28","type":"dividend","market":"US","newRecordDate":"2024-04-02","defaultRemindTime":1711978200000,"name":"VanEck Pharmaceutical ETF","recordDate":"2024-04-05","payableDate":"2024-04-02","currency":"USD","dateTimestamp":1711944000000,"payDate":"2024-04-05"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PPH\",market:\"US\",,,undefined,":[{"executeDate":"2015-07-01","recordDate":"2015-07-06","paymentDate":"2015-07-08","value":0.2769,"currency":"USD"},{"executeDate":"2015-10-01","recordDate":"2015-10-05","paymentDate":"2015-10-07","value":0.284,"currency":"USD"},{"executeDate":"2015-12-29","recordDate":"2015-12-31","paymentDate":"2016-01-05","value":0.204,"currency":"USD"},{"executeDate":"2016-04-01","recordDate":"2016-04-05","paymentDate":"2016-04-07","value":0.627,"currency":"USD"},{"executeDate":"2016-07-01","recordDate":"2016-07-06","paymentDate":"2016-07-08","value":0.2867,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PPH\",market:\"US\",delay:false,,,undefined,":{}}}